Company Filing History:
3 out of 61 
2 out of 1,744 
1 out of 870 
Years Active: 1999-2000
Title: Elisabeth Gomard: Innovator in Immunology
Introduction
Elisabeth Gomard is a prominent inventor based in Paris, France. She has made significant contributions to the field of immunology, particularly through her innovative work on lipopeptides. With a total of 3 patents, her research focuses on developing vaccines that can effectively combat pathogenic agents.
Latest Patents
Elisabeth's latest patents include groundbreaking work on cytotoxic T lymphocyte-inducing lipopeptides. These lipopeptides comprise a peptide part that has between 10 and 40 amino acids and includes at least one antigenic determinant. They also contain one or more chains derived from fatty acids and modified steroid groups. These lipopeptides are designed for immunizing the human or animal body against viruses and parasites. Notably, the peptide part may be a fragment of the protein encoded by the ENV, NEF, or GAG genes of HIV viruses.
Career Highlights
Throughout her career, Elisabeth has worked with esteemed institutions such as the Institut Pasteur de Lille and the Institut National de la Santé et de la Recherche Médicale. Her research has been pivotal in advancing the understanding of immunological responses and vaccine development.
Collaborations
Elisabeth has collaborated with notable colleagues, including Christophe Boutillon and Frederic Martinon. These partnerships have further enriched her research and contributed to her innovative projects.
Conclusion
Elisabeth Gomard stands out as a leading inventor in the field of immunology, with her patents paving the way for new vaccine technologies. Her work continues to have a significant impact on the fight against infectious diseases.